To elucidate the involved mechanism of DCLK1‐mediated cancer stemness and 5‐fluorouracil resistance in CRC, we performed mass spectrometry (MS) to identify DCLK1‐binding proteins in cells (Figure 3A). This evidence concerns the gene DCLK1 and colorectal carcinoma.